EP 1000017 A1 20000517 - IL-8 RECEPTOR ANTAGONISTS
Title (en)
IL-8 RECEPTOR ANTAGONISTS
Title (de)
ANTAGONISTEN DES IL-8-REZEPTORS
Title (fr)
ANTAGONISTES DU RECEPTEUR IL-8
Publication
Application
Priority
- US 9815830 W 19980729
- US 5400197 P 19970729
Abstract (en)
[origin: WO9906354A1] This invention relates to novel phenyl ureas useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
IPC 1-7
IPC 8 full level
A61K 31/216 (2006.01); A61P 1/00 (2006.01); A61P 7/02 (2006.01); A61P 9/04 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 13/12 (2006.01); A61P 17/06 (2006.01); A61P 19/08 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 37/00 (2006.01); A61P 43/00 (2006.01); C07C 275/42 (2006.01)
CPC (source: EP)
A61P 1/00 (2017.12); A61P 7/02 (2017.12); A61P 9/04 (2017.12); A61P 9/10 (2017.12); A61P 11/00 (2017.12); A61P 11/06 (2017.12); A61P 13/12 (2017.12); A61P 17/06 (2017.12); A61P 19/08 (2017.12); A61P 25/28 (2017.12); A61P 29/00 (2017.12); A61P 37/00 (2017.12); A61P 43/00 (2017.12); C07C 275/42 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9906354 A1 19990211; AU 8673198 A 19990222; CA 2294064 A1 19990211; EP 1000017 A1 20000517; EP 1000017 A4 20001018; JP 2001512096 A 20010821
DOCDB simple family (application)
US 9815830 W 19980729; AU 8673198 A 19980729; CA 2294064 A 19980729; EP 98938138 A 19980729; JP 2000505116 A 19980729